Please sign in to follow a disease.
Vulvar carcinoma
MONDO:0005215A carcinoma that arises from epithelial cells of the mammalian vulva
Also known as: cancer of the vulva, cancer of vulva, vulva cancer, vulvar cancer, carcinoma of mammalian vulva, carcinoma of the vulva, carcinoma of vulva, mammalian vulva carcinoma
2879 clinical trials for this condition and its sub-types, 24 tagged with Vulvar carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Vulvar carcinoma
-
Vulvar squamous cell carcinoma 22 trials
6 sub-types
- Bartholin gland squamous cell carcinoma 0 trials Sub-types →
- Vulva verrucous carcinoma 0 trials
- Vulvar basaloid squamous cell carcinoma 0 trials
- Vulvar keratinizing squamous cell carcinoma 0 trials
- Vulvar keratoacanthoma-like carcinoma 0 trials
- Vulvar non-keratinizing squamous cell carcinoma 0 trials
-
Vulvar adenocarcinoma 3 trials · 5 incl. sub-types
7 sub-types
- Vulval Paget disease 2 trials
- Bartholin gland adenocarcinoma 0 trials Sub-types →
- Adenocarcinoma of skene gland origin 0 trials
- Vulvar apocrine adenocarcinoma 0 trials
- Vulvar clear cell hidradenocarcinoma 0 trials
- Vulvar eccrine adenocarcinoma 0 trials Sub-types →
- Vulvar sebaceous carcinoma 0 trials
-
Bartholin gland carcinoma 0 trials · 1 incl. sub-types
4 sub-types
-
Clitoral carcinoma 0 trials
-
Labia majora carcinoma 0 trials
-
Labia minora carcinoma 0 trials
-
Vulva basal cell carcinoma 0 trials
-
Vulvar neuroendocrine carcinoma 0 trials
1 sub-type
- Bartholin gland small cell carcinoma 0 trials
-
Vulvar seborrheic keratosis 0 trials
1 sub-type
- Vulvar inverted follicular keratosis 0 trials
Most studied deeper sub-types
-
Engineered immune cells take on HPV cancers in early trial
Disease control CompletedThis study tested a new experimental treatment called HPVST cells in 32 people with HPV-related cancers that had returned or not responded to standard care. The cells are grown from the patient's own blood and trained to attack HPV-infected cancer cells. The goal was to find a sa…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Blood test may catch pelvic cancer relapse sooner
Diagnosis CompletedThis study looks at whether a blood test that detects tumor DNA can find early signs of cancer returning in people treated for HPV-positive pelvic cancers (like cervical or anal cancer). Researchers will take blood samples from 172 patients during regular follow-up visits. The go…
Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Cancer Survivors' sex drive gets a boost: bupropion shows promise
Symptom relief CompletedThis study tested whether bupropion, a medication that affects brain chemicals, can improve low sexual desire in women who have had breast or gynecologic cancer. About 230 women took either bupropion or a placebo pill for 9 weeks. The main goal was to see if their self-reported s…
Phase 2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New biomarker may predict which cancer drugs work best
Knowledge-focused CompletedThis completed study tested whether a new biomarker called 'mass response' can predict how well a cancer therapy will work. Researchers collected tumor cells from 72 patients with various cancers through fluid drainage or biopsies. The goal was to see if this biomarker could guid…
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC